Great Point Partners LLC
- SEC CIK
- 0001281446
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 40
- 較 2022 年第 2 季 +7
- 總值
- $4.15 億
- 較 2022 年第 2 季 +$2,717 萬 (+7.0%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | COM | 850,000 | $3,069 萬 | 7.4% | −254,334−23.0% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 215,000 | $2,866 萬 | 6.9% | +25,000+13.2% | 加碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 3,560,984 | $2,753 萬 | 6.6% | +1,140,483+47.1% | 加碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 3,448,521 | $2,483 萬 | 6.0% | +2,909,702+540.0% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 966,108 | $2,381 萬 | 5.7% | −5,125−0.5% | 減碼 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 5,645,161 | $2,348 萬 | 5.7% | +5,645,161 | 新進 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,551,719 | $2,252 萬 | 5.4% | +21,719+1.4% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 1,041,737 | $2,176 萬 | 5.2% | +684,474+191.6% | 加碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 510,000 | $1,888 萬 | 4.5% | −190,000−27.1% | 減碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 1,019,282 | $1,604 萬 | 3.9% | −63,718−5.9% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 600,000 | $1,440 萬 | 3.5% | −385,153−39.1% | 減碼 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 306,411 | $1,307 萬 | 3.1% | −53,589−14.9% | 減碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 1,200,000 | $1,204 萬 | 2.9% | −315,000−20.8% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 507,500 | $1,133 萬 | 2.7% | +145,864+40.3% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 76,500 | $1,047 萬 | 2.5% | +76,500 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,050,000 | $1,044 萬 | 2.5% | +1,050,000 | 新進 | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 301,324 | $988.9 萬 | 2.4% | −367,876−55.0% | 減碼 | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 269,967 | $942.5 萬 | 2.3% | −119,256−30.6% | 減碼 | 歷史 |
| TCDATricida, Inc. | COM | 870,000 | $911.8 萬 | 2.2% | −294,763−25.3% | 減碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 315,000 | $757.9 萬 | 1.8% | +315,000 | 新進 | 歷史 |
| URGNUroGen Pharma Ltd. | COM | 873,424 | $726.7 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 390,000 | $673.5 萬 | 1.6% | +390,000 | 新進 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 95,500 | $620.7 萬 | 1.5% | +95,500 | 新進 | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 674,656 | $620.0 萬 | 1.5% | +674,656 | 新進 | 歷史 |
| ETNB89bio, Inc. | COM | 955,000 | $552.9 萬 | 1.3% | −445,000−31.8% | 減碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 825,077 | $438.1 萬 | 1.1% | +825,077 | 新進 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 316,256 | $413.7 萬 | 1.0% | +316,256 | 新進 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 492,000 | $381.8 萬 | 0.9% | +60,000+13.9% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 78,527 | $368.6 萬 | 0.9% | +78,527 | 新進 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 1,135,000 | $363.2 萬 | 0.9% | +1,135,000 | 新進 | 歷史 |
| DTILPrecision Biosciences Inc | COM | 2,710,805 | $352.4 萬 | 0.8% | −3,044,591−52.9% | 減碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 799,439 | $279.8 萬 | 0.7% | +799,439 | 新進 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 1,965,449 | $226.0 萬 | 0.5% | −547,051−21.8% | 減碼 | – |
| ICPTIntercept Pharmaceuticals, Inc. | COM | 105,000 | $146.5 萬 | 0.4% | +105,000 | 新進 | 歷史 |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 449,049 | $144.6 萬 | 0.3% | +449,049 | 新進 | – |
| DNTHDianthus Therapeutics, Inc. | COM | 1,019,091 | $143.7 萬 | 0.3% | −150,909−12.9% | 減碼 | 歷史 |
| NKTRNektar Therapeutics | COM | 447,820 | $143.3 萬 | 0.3% | −2,702,180−85.8% | 減碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 70,621 | $141.5 萬 | 0.3% | +70,621 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 2,500,000 | $131.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 68,915 | $69.2 萬 | 0.2% | −332,534−82.8% | 減碼 | 歷史 |
2022 年第 2 季之後清倉（8 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CYTKCytokinetics Inc | COM NEW | 610,000 | $2,397 萬 | 6.2% | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 149,000 | $1,885 萬 | 4.9% | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 193,900 | $1,454 萬 | 3.7% | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 1,204,028 | $1,167 萬 | 3.0% | 歷史 |
| ANABAnaptysbio, Inc | COM | 453,118 | $919.8 萬 | 2.4% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 75,000 | $731.1 萬 | 1.9% | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 500,000 | $726.5 萬 | 1.9% | – |
| KDNYChinook Therapeutics, Inc. | COM | 336,731 | $588.9 萬 | 1.5% | 歷史 |